Companies from the two countries discussed bringing Uzbek pharmaceutical products to the Tajik market, localizing medicines and medical equipment, and developing joint production projects. However, contracts, shipment volumes and delivery timelines have not yet been announced.
Uzbekistan and Tajikistan intend to expand cooperation in the pharmaceutical sector. Prospects for supplying medicines and medical equipment, as well as establishing joint ventures, were discussed on August 24, 2026, during a bilateral business forum in Tashkent.
Abdulla Azizov, Director of Uzbekistan’s Agency for the Development of the Medical and Pharmaceutical Industry, met with a delegation led by Salomuddin Yusufi, First Deputy Minister of Health and Social Protection of the Population of Tajikistan.
The forum brought together representatives of Tajikistan’s Ministry of Health, the State Supervision Service and its Sughd Region department, the state enterprise “Expertise and Testing of Pharmaceutical and Medical Products,” as well as manufacturers and other industry companies from both countries.
Uzbek Companies Seek Access to the Tajik Market
The forum included B2B meetings between Uzbek manufacturers and Tajik companies. The participants discussed specific proposals for bringing pharmaceutical products to the Tajik market and increasing bilateral trade.
Tajik partners were presented with medicines and medical equipment manufactured in Uzbekistan. The names of the companies and products that could become the first export items have not been officially disclosed.
The expected contract values, shipment volumes and timelines for the start of regular supplies have also not been announced. The negotiations therefore remain at the stage of developing projects and establishing direct business ties rather than implementing signed export agreements.
Countries Consider Joint Production
Cooperation could go beyond the export of finished medicines. Forum participants discussed industrial cooperation, the localization of medicines and medical equipment, technology transfer and joint investment projects.
Local production could reduce dependence on finished-product imports and bring pharmaceutical manufacturing closer to the end market. For Uzbek companies, it could also create a long-term presence in Tajikistan, while Tajik partners could gain access to technology and manufacturing expertise.
Tajik Delegation Visits Pharmaceutical Production and Logistics Facilities
Representatives of Tajikistan visited the BioPharma City pharmaceutical cluster. The delegation was shown ongoing projects, infrastructure, existing production facilities and opportunities for establishing localized manufacturing.
The guests also visited the site of the Pharmaceutical Technical University, which is under construction, and were introduced to its planned educational capabilities.
Another stop was the Grand Pharm Logistics center, where Tajik representatives were shown the processes of receiving, storing, sorting and delivering pharmaceutical products.
Pharmaceutical Production in Uzbekistan Grows by 22.3%
The discussions with Tajikistan are taking place against the backdrop of growth in Uzbekistan’s pharmaceutical industry. According to the National Statistics Committee, large enterprises in the country produced nearly UZS 3 trillion worth of pharmaceutical products and medicines in January–June 2026.
The figure was 22.3% higher than in the same period of 2025. Tashkent accounted for the largest share of production, at UZS 1.8 trillion, followed by the Syrdarya and Tashkent regions.
Contracts and Timelines Still to Be Agreed
Following the forum, the two sides agreed to develop direct contacts between manufacturers and continue practical negotiations on potential projects.
The Tashkent forum confirmed the mutual interest of Uzbekistan and Tajikistan in expanding pharmaceutical trade. The next indicators of practical progress will be signed contracts and the launch of specific export or joint production projects.
Read also: Bulgaria Plans a 300-Metre Danube Dike to Protect Kozloduy Nuclear Plant
